The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Open accessAbstract
Diabetic retinopathy (DR), with increasing incidence, is the major cause of vision loss and blindness worldwide in working-age adults. Diabetic macular edema (DME) remains the main cause of vision impairment in diabetic patients, with its pathogenesis still not completely elucidated. Vascular endothelial growth factor (VEGF) plays a pivotal role in the pathogenesis of DR and DME. Currently, intravitreal injection of anti-VEGF agents remains as the first-line therapy in DME treatment due to the superior anatomic and functional outcomes. However, some patients do not respond satisfactorily to anti-VEGF injections. More than 30% patients still exist with persistent DME even after regular intravitreal injection for at least 4 injections within 24 weeks, suggesting other pathogenic factors, beyond VEGF, might contribute to the pathogenesis of DME. Recent advances showed nearly all the retinal cells are involved in DR and DME, including breakdown of blood-retinal barrier (BRB), drainage dysfunction of Müller glia and retinal pigment epithelium (RPE), involvement of inflammation, oxidative stress, and neurodegeneration, all complicating the pathogenesis of DME. The profound understanding of the changes in proteomics and metabolomics helps improve the elucidation of the pathogenesis of DR and DME and leads to the identification of novel targets, biomarkers and potential therapeutic strategies for DME treatment. The present review aimed to summarize the current understanding of DME, the involved molecular mechanisms, and the changes in proteomics and metabolomics, thus to propose the potential therapeutic recommendations for personalized treatment of DME.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Reactive Oxygen Species in Inflammation and Tissue Injury
Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
ilastik: interactive machine learning for (bio)image analysis
Berg, S., Kutra, D., Kroeger, T., Straehle, C. N., Kausler, B. X., Haubold, C., Schiegg, M., Ales, J., Beier, T., Rudy, M., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0582-9 · Cited by 3,368
Self-citationVEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Ranibizumab for Diabetic Macular Edema
Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A. C., Hopkins, J. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.039 · Cited by 1,621
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,176
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Boyer, D. S., Yoon, Y. H., Belfort, R., Bandello, F., Maturi, R. K., Augustin, A. J., Li, X.-Y., Cui, H., Hashad, Y., & Whitcup, S. M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.024 · Cited by 1,122
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100
Kang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040 · cited 1×
“IL-6 signaling occurs through its membranebound receptor IL-6R (classical signaling) or through the soluble IL-6R (sIL-6R, transsignaling) [198,199].”
BackgroundFrank, R. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmra021678 · Cited by 891
Miyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Role of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750
Oxidative Stress and Diabetic Retinopathy
Kowluru, R. A., & Chan, P.-S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/43603 · Cited by 746
Reichenbach, A., & Bringmann, A. (2013) · Glia · doi:10.1002/glia.22477 · Cited by 714
Mechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708
Patterns of diabetic macular edema with optical coherence tomography
Otani, T., Kishi, S., & Maruyama, Y. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00033-1 · Cited by 705
Pharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Sohn, E. H., van Dijk, H. W., Jiao, C., Kok, P. H. B., Jeong, W., Demirkaya, N., Garmager, A., Wit, F., Kucukevcilioglu, M., van Velthoven, M. E. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522014113 · Cited by 682
Intravitreal Aflibercept for Diabetic Macular Edema
Brown, D. M., Schmidt-Erfurth, U., Do, D. V., Holz, F. G., Boyer, D. S., Midena, E., Heier, J. S., Terasaki, H., Kaiser, P. K., Marcus, D. M., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.06.017 · Cited by 623
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina
Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S.-E., & Adamis, A. P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63952-1 · Cited by 567
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 551
Cunha-Vaz, J., Bernardes, R., & Lobo, C. (2011) · European Journal of Ophthalmology · doi:10.5301/ejo.2010.6049 · Cited by 539
Krady, J. K., Basu, A., Allen, C. M., Xu, Y., LaNoue, K. F., Gardner, T. W., & Levison, S. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1559 · Cited by 529
Campochiaro, P. A., Brown, D. M., Pearson, A., Chen, S., Boyer, D., Ruiz-Moreno, J., Garretson, B., Gupta, A., Hariprasad, S. M., Bailey, C., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.030 · Cited by 517
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041264 · Cited by 512
Wykoff, C. C., Abreu, F., Adamis, A. P., Basu, K., Eichenbaum, D. A., Haskova, Z., Lin, H., Loewenstein, A., Mohan, S., Pearce, I. A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00018-6 · Cited by 504
Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
Simó, R., & Hernández, C. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.005 · Cited by 490
Simó, R., Villarroel, M., Corraliza, L., Hernández, C., & Garcia-Ramírez, M. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/190724 · Cited by 463
The Role of Inflammation in Diabetic Retinopathy
Forrester, J. V., Kuffova, L., & Delibegovic, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583687 · Cited by 432
Retinal ganglion cells in diabetes
Kern, T. S., & Barber, A. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.156695 · Cited by 422
Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
Romero-Aroca, P., Baget-Bernaldiz, M., Pareja-Rios, A., Lopez-Galvez, M., Navarro-Gil, R., & Verges, R. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2156273 · Cited by 404
Microglial Activation in Human Diabetic Retinopathy
Zeng, H.-Y. (2008) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2007.65 · Cited by 402
Altmann, C., & Schmidt, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010110 · Cited by 402
Role of microglia in CNS inflammation
Graeber, M. B., Li, W., & Rodriguez, M. L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.033 · Cited by 392 · cited 1×
“model [73], which facilitated the migration of the inflammatory cells.”
BackgroundRajendram, R., Fraser-Bell, S., Kaines, A., Michaelides, M., Hamilton, R. D., Esposti, S. D., Peto, T., Egan, C., Bunce, C., Leslie, R. D., et al. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2012.393 · Cited by 389
Bressler, N. M., Beaulieu, W. T., Glassman, A. R., Blinder, K. J., Bressler, S. B., Jampol, L. M., Melia, M., Wells, J. A., & for the Diabetic Retinopathy Clinical Research Network (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.6565 · Cited by 343
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
Schmidt-Erfurth, U., Lang, G. E., Holz, F. G., Schlingemann, R. O., Lanzetta, P., Massin, P., Gerstner, O., Bouazza, A. S., Shen, H., Osborne, A., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.041 · Cited by 325
Immunological mechanisms in the pathogenesis of diabetic retinopathy
Adamis, A. P., & Berman, A. J. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0111-x · Cited by 322
Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina
Park, S.-H., Park, J.-W., Park, S.-J., Kim, K.-Y., Chung, J.-W., Chun, M.-H., & Oh, S.-J. (2003) · Diabetologia · doi:10.1007/s00125-003-1177-6 · Cited by 322
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
Brines, M., Patel, N. S. A., Villa, P., Brines, C., Mennini, T., De Paola, M., Erbayraktar, Z., Erbayraktar, S., Sepodes, B., Thiemermann, C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805594105 · Cited by 319
Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists
Mitoma, H., Horiuchi, T., Tsukamoto, H., & Ueda, N. (2018) · Cytokine · doi:10.1016/j.cyto.2016.08.014 · Cited by 316
Sun, Z., Tang, F., Wong, R., Lok, J., Szeto, S. K. H., Chan, J. C. K., Chan, C. K. M., Tham, C. C., Ng, D. S., & Cheung, C. Y. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.06.016 · Cited by 307
Müller cells as players in retinal degeneration and edema
Reichenbach, A., Wurm, A., Pannicke, T., Iandiev, I., Wiedemann, P., & Bringmann, A. (2007) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0516-y · Cited by 305
Expression of Apoptosis Markers in the Retinas of Human Subjects with Diabetes
El-Asrar, A. M. A., Dralands, L., Missotten, L., Al-Jadaan, I. A., & Geboes, K. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1392 · Cited by 292
Pathology of human cystoid macular edema
Yanoff, M., Fine, B. S., Brucker, A. J., & Eagle, R. C. (1984) · Survey of Ophthalmology · doi:10.1016/0039-6257(84)90233-9 · Cited by 291
Pathomechanisms of Cystoid Macular Edema
Bringmann, A., Reichenbach, A., & Wiedemann, P. (2004) · Ophthalmic Research · doi:10.1159/000081203 · Cited by 286
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Campochiaro, P. A., Marcus, D. M., Awh, C. C., Regillo, C., Adamis, A. P., Bantseev, V., Chiang, Y., Ehrlich, J. S., Erickson, S., Hanley, W. D., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.03.036 · Cited by 272
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
Barouch, F. C., Miyamoto, K., Allport, J. R., Fujita, K., Bursell, S., Aiello, L. P., Luscinskas, F. W., & Adamis, A. P. (2000) · PubMed · Cited by 264
Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
Abcouwer, S. F., & Gardner, T. W. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12412 · Cited by 254
Barnes, T. C., Anderson, M. E., & Moots, R. J. (2011) · International Journal of Rheumatology · doi:10.1155/2011/721608 · Cited by 244
Rangasamy, S., McGuire, P. G., Franco Nitta, C., Monickaraj, F., Oruganti, S. R., & Das, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108508 · Cited by 243
Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
Simó, R., & Hernández, C. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.04.003 · Cited by 239
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Krohne, T. U., Liu, Z., Holz, F. G., & Meyer, C. H. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.047 · Cited by 238
Heier, J. S., Kherani, S., Desai, S., Dugel, P., Kaushal, S., Cheng, S. H., Delacono, C., Purvis, A., Richards, S., Le-Halpere, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30979-0 · Cited by 229 · cited 1×
“The potential effect of rAAV-sFlt1 on DME deserves further study [155].”
BackgroundRETINAL VASCULAR CYSTOID MACULAR EDEMA: Review and New Theory
Spaide, R. F. (2016) · Retina · doi:10.1097/iae.0000000000001158 · Cited by 229
Zhang, J., Wu, Y., Jin, Y., Ji, F., Sinclair, S. H., Luo, Y., Xu, G., Lu, L., Dai, W., Yanoff, M., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0721 · Cited by 226
Self-citationChemokines and Glial Cells: A Complex Network in the Central Nervous System
Ambrosini, E., & Aloisi, F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000021246.96864.89 · Cited by 218
Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy
Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105115 · Cited by 217
A potassium channel-linked mechanism of glial cell swelling in the postischemic retina
Pannicke, T., Iandiev, I., Uckermann, O., Biedermann, B., Kutzera, F., Wiedemann, P., Wolburg, H., Reichenbach, A., & Bringmann, A. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.04.005 · Cited by 216
Huang, H., Gandhi, J. K., Zhong, X., Wei, Y., Gong, J., Duh, E. J., & Vinores, S. A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5768 · Cited by 215
Kofuji, P., Biedermann, B., Siddharthan, V., Raap, M., Iandiev, I., Milenkovic, I., Thomzig, A., Veh, R. W., Bringmann, A., & Reichenbach, A. (2002) · Glia · doi:10.1002/glia.10112 · Cited by 215
FUNATSU, H., YAMASHITA, H., SAKATA, K., NOMA, H., MIMURA, T., SUZUKI, M., EGUCHI, S., & HORI, S. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.045 · Cited by 209
Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
Semeraro, F., Morescalchi, F., Cancarini, A., Russo, A., Rezzola, S., & Costagliola, C. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.04.002 · Cited by 205
Role of NADPH Oxidase in Retinal Vascular Inflammation
Al-Shabrawey, M., Rojas, M., Sanders, T., Behzadian, A., El-Remessy, A., Bartoli, M., Parpia, A. K., Liou, G., & Caldwell, R. B. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1755 · Cited by 202
Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service
Thomas, R. L., Dunstan, F. D., Luzio, S. D., Chowdhury, S. R., North, R. V., Hale, S. L., Gibbins, R. L., & Owens, D. R. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304017 · Cited by 202
Li, J., Wang, J. J., Yu, Q., Chen, K., Mahadev, K., & Zhang, S. X. (2010) · Diabetes · doi:10.2337/db09-1057 · Cited by 199
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Glassman, A. R., Wells, J. A., Josic, K., Maguire, M. G., Antoszyk, A. N., Baker, C., Beaulieu, W. T., Elman, M. J., Jampol, L. M., & Sun, J. K. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.03.021 · Cited by 198
Rakoczy, E. P., Lai, C.-M., Magno, A. L., Wikstrom, M. E., French, M. A., Pierce, C. M., Schwartz, S. D., Blumenkranz, M. S., Chalberg, T. W., Degli-Esposti, M. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00345-1 · Cited by 189
Holekamp, N. M., Campochiaro, P. A., Chang, M. A., Miller, D., Pieramici, D., Adamis, A. P., Brittain, C., Evans, E., Kaufman, D., Maass, K. F., et al. (2022) · Ophthalmology · doi:10.1016/j.ophtha.2021.09.016 · Cited by 189
Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy
Youngblood, H., Robinson, R., Sharma, A., & Sharma, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194755 · Cited by 180
Fachinger, G., Deutsch, U., & Risau, W. (1999) · Oncogene · doi:10.1038/sj.onc.1202992 · Cited by 180
Inflammatory and angiogenic biomarkers in diabetic retinopathy
Kaštelan, S., Orešković, I., Bišćan, F., Kaštelan, H., & Gverović Antunica, A. (2020) · Biochemia medica · doi:10.11613/bm.2020.030502 · Cited by 178
Shirley, M. (2022) · Drugs · doi:10.1007/s40265-022-01713-3 · Cited by 176
Barrier analysis of periocular drug delivery to the posterior segment
Ranta, V.-P., Mannermaa, E., Lummepuro, K., Subrizi, A., Laukkanen, A., Antopolsky, M., Murtomäki, L., Hornof, M., & Urtti, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.028 · Cited by 173
Brown, D. M., Emanuelli, A., Bandello, F., Barranco, J. J. E., Figueira, J., Souied, E., Wolf, S., Gupta, V., Ngah, N. F., Liew, G., et al. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.01.004 · Cited by 169
Metabolomics in the study of retinal health and disease
Laíns, I., Gantner, M. L., Murinello, S., Lasky-Su, J. A., Miller, J. W., Friedlander, M., & Husain, D. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.002 · Cited by 168
Zhao, M., Valamanesh, F., Celerier, I., Savoldelli, M., Jonet, L., Jeanny, J., Jaisser, F., Farman, N., & Behar‐Cohen, F. (2010) · The FASEB Journal · doi:10.1096/fj.09-154344 · Cited by 166
Sustained Delivery Fluocinolone Acetonide Vitreous Implants
Cunha-Vaz, J. G., Ashton, P., Iezzi, R., Campochiaro, P. A., Dugel, P. U., Holz, F. G., Weber, M., Danis, R. P., Kuppermann, B. D., Bailey, C., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.019 · Cited by 160
Jo, D. H., Yun, J., Cho, C. S., Kim, J. H., Kim, J. H., & Cho, C. (2018) · Glia · doi:10.1002/glia.23542 · Cited by 159
Treatment of Diabetic Macular Edema
Kim, E. J., Lin, W. V., Rodriguez, S. M., Chen, A., Loya, A., & Weng, C. Y. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1188-4 · Cited by 153
Constable, I. J., Pierce, C. M., Lai, C.-M., Magno, A. L., Degli-Esposti, M. A., French, M. A., McAllister, I. L., Butler, S., Barone, S. B., Schwartz, S. D., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.016 · Cited by 152
Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
Bhargava, P., & Robinson, M. O. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0154-3 · Cited by 141
Brown, D. M., Emanuelli, A., Bandello, F. M., Escobar-Barranco, J. J., Figueira, J., Souied, E. H., Wolf, S., Gupta, V., Ngah, N. F., Liew, G., et al. (2022) · doi:10.48350/181493 · Cited by 140
Yang, L., Costa, M. B. ́., & Gerhardinger, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036949 · Cited by 139
Feng, S., Yu, H., Yu, Y., Geng, Y., Li, D., Yang, C., Lv, Q., Li, L., Liu, T., Li, G., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8546423 · Cited by 139
Im, J. H. B., Jin, Y.-P., Chow, R., & Yan, P. (2022) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2022.01.009 · Cited by 136
SUBVISIBLE RETINAL LASER THERAPY
Lavinsky, D., Sramek, C., Wang, J. Y., Huie, P., Dalal, R., Mandel, Y., & Palanker, D. (2013) · Retina · doi:10.1097/iae.0b013e3182993edc · Cited by 132
Grishanin, R., Vuillemenot, B., Sharma, P., Keravala, A., Greengard, J., Gelfman, C., Blumenkrantz, M., Lawrence, M., Hu, W., Kiss, S., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.11.003 · Cited by 127
Minocycline and Doxycycline: More Than Antibiotics
Singh, S., Khanna, D., & Kalra, S. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210210122628 · Cited by 126
Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium
Xia, T., & Rizzolo, L. J. (2017) · Vision Research · doi:10.1016/j.visres.2017.02.006 · Cited by 125
Wu, F., Phone, A., Lamy, R., Ma, D., Laotaweerungsawat, S., Chen, Y., Zhao, T., Ma, W., Zhang, F., Psaras, C., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.2.26 · Cited by 125
NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy
Wilkinson‐Berka, J. L., Deliyanti, D., Rana, I., Miller, A. G., Agrotis, A., Armani, R., Szyndralewiez, C., Wingler, K., Touyz, R. M., Cooper, M. E., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5357 · Cited by 123
Shen, J., Wu, Y., Xu, J., Zhang, J., Sinclair, S. H., Yanoff, M., Xu, G., Li, W., & Xu, G. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3544 · Cited by 123
Self-citationTabrizi, Y. T., Hassanshahi, G., Kounis, N. G., Koniari, I. C., & Khorramdelazad, H. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-00500-8 · Cited by 123
Campochiaro, P. A., Khanani, A. M., Singer, M. A., Patel, S. S., Boyer, D. S., Dugel, P. U., Kherani, S., Withers, B., Gambino, L., Peters, K. G., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.04.025 · Cited by 121
McVicar, C., Hamilton, R. W., Colhoun, L. M., Gardiner, T. A., Brines, M. L., Cerami, A., & Stitt, A. W. (2011) · Diabetes · doi:10.2337/db11-0026 · Cited by 118
Pericytes, inflammation, and diabetic retinopathy
Spencer, B. G., Estevez, J. J., Liu, E., Craig, J. E., & Finnie, J. W. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00647-9 · Cited by 118
Innovative therapies for neovascular age-related macular degeneration
Al-Khersan, H., Hussain, R. M., Ciulla, T. A., & Dugel, P. U. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1636031 · Cited by 114 · cited 2×
“ARP-1536 is intravitreally administered, currently undergoing preclinical studies [161].”
BackgroundEsser, P., Heimann, K., & Wiedemann, P. (1993) · British Journal of Ophthalmology · doi:10.1136/bjo.77.11.731 · Cited by 114
del Valle, M. L., Dworshak, J., Sharma, A. K., Ibrahim, A. S., Al‐Shabrawey, M., & Sharma, S. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.09.009 · Cited by 114
Campochiaro, P. A., Channa, R., Berger, B. B., Heier, J. S., Brown, D. M., Fiedler, U., Hepp, J., & Stumpp, M. T. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.09.032 · Cited by 112
Cukras, C. A., Petrou, P. A., Chew, E. Y., MEYERLE, C. B., & Wong, W. T. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9413 · Cited by 112
Fort, P. E., Sène, A., Pannicke, T., Roux, M. J., Forster, V., Mornet, D., Nudel, U., Yaffe, D., Reichenbach, A., Sahel, J., et al. (2008) · Glia · doi:10.1002/glia.20633 · Cited by 112
Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease
Hussain, R. M., Neiweem, A. E., Kansara, V. S., Harris, A., & Ciulla, T. A. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1667333 · Cited by 109
Topical Dexamethasone-Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema
Tanito, M., Hara, K., Takai, Y., Matsuoka, Y., Nishimura, N., Jansook, P., Loftsson, Þ., Stefánsson, E., & Ohira, A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8178 · Cited by 108
Oshitari, T., Yamamoto, S., Hata, N., & Roy, S. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.132308 · Cited by 108
Xie, H., Zhang, C., Liu, D., Yang, Q., Tang, L., Wang, T., Tian, H., Lü, L., Xu, J., Gao, F., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05299-x · Cited by 107
Self-citationRetinal Gene Expression and Müller Cell Responses after Branch Retinal Vein Occlusion in the Rat
Rehák, M., Hollborn, M., Iandiev, I., Pannicke, T., Karl, A., Wurm, A., Kohen, L., Reichenbach, A., Wiedemann, P., & Bringmann, A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2332 · Cited by 106
Simó, R., Hernández, C., Porta, M., Bandello, F. M., Grauslund, J., Harding, S. P., Aldington, S. J., Egan, C. A., Frydkjær-Olsen, U., García‐Arumí, J., et al. (2018) · Diabetes · doi:10.2337/db18-0682 · Cited by 106
Novel therapeutic targets in diabetic macular edema: Beyond VEGF
Urias, E. A., Urias, G. A., Monickaraj, F., McGuire, P. G., & Das, A. (2017) · Vision Research · doi:10.1016/j.visres.2017.06.015 · Cited by 104
Weekes, C. D., Beeram, M., Tolcher, A. W., Papadopoulos, K. P., Gore, L., Hegde, P. S., Xin, Y., Yu, R., Shih, L. M., Xiang, H., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0071-z · Cited by 102
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain
Korenfeld, M. S., Silverstein, S., Cooke, D. L., Vogel, R., & Crockett, R. S. (2008) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2008.09.024 · Cited by 102
Biosimilars in ophthalmology: “Is there a big change on the horizon?”
Sharma, A., Reddy, P., Kuppermann, B. D., Bandello, F. M., & Loewenstein, A. (2018) · Clinical ophthalmology · doi:10.2147/opth.s180393 · Cited by 99
Proteomic analysis of vitreous from diabetic macular edema
Ouchi, M., West, K. A., Crabb, J. W., Kinoshita, S., & Kamei, M. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.020 · Cited by 98
Patnaik, A., LoRusso, P. M., Messersmith, W. A., Papadopoulos, K. P., Gore, L., Beeram, M., Ramakrishnan, V., Kim, A. H., Beyer, J. C., Shih, L. M., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2426-8 · Cited by 93
Hussain, R. M., Shaukat, B. A., Ciulla, L. M., Berrocal, A. M., & Sridhar, J. S. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s295223 · Cited by 93
Sfikakis, P. P., Markomichelakis, N. N., THEODOSSIADIS, G. P., Grigoropoulos, V. G., Katsilambros, N., & Theodossiadis, P. G. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.445 · Cited by 92
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration
Kunimoto, D., Yoon, Y. H., Wykoff, C. C., Chang, A., Khurana, R. N., Maturi, R. K., Agostini, H., Souied, E., Chow, D. R., Lotery, A. J., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.03.035 · Cited by 91
Souied, E. H., Devin, F., Mauget‐Faÿsse, M., Kolář, P., Wolf-Schnurrbusch, U. E. K., Framme, C., Gaucher, D., Querques, G., Stumpp, M. T., & Wolf, S. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.05.037 · Cited by 91
Pathologic Alterations of the Outer Retina in Streptozotocin-Induced Diabetes
Énzsöly, A., Szabó, A., Kántor, O., Dávid, C., Szalay, P., Szabó, K., Szél, Á., Németh, J., & Lukáts, Á. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13562 · Cited by 89
Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
Samanta, A., Aziz, A. A., Jhingan, M., Singh, S. R., Khanani, A. M., & Chhablani, J. K. (2020) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000291 · Cited by 85
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Campochiaro, P. A., & Peters, K. G. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0816-5 · Cited by 83
Membrane polarity in epithelial cells: protein sorting and establishment of polarized domains
Caplan, M. J. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.272.4.f425 · Cited by 80
Ramucirumab: First Global Approval
Poole, R. M., & Vaidya, A. (2014) · Drugs · doi:10.1007/s40265-014-0244-2 · Cited by 78
Microglia mediate non‐cell‐autonomous cell death of retinal ganglion cells
Takeda, A., Shinozaki, Y., Kashiwagi, K., Ohno, N., Eto, K., Wake, H., Nabekura, J., & Koizumi, S. (2018) · Glia · doi:10.1002/glia.23475 · Cited by 77
Plasma kallikrein-kinin system and diabetic retinopathy
Liu, J., & Feener, E. P. (2013) · Biological Chemistry · doi:10.1515/hsz-2012-0316 · Cited by 76
Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
Gaynes, B. I. (2008) · Clinical ophthalmology · doi:10.2147/opth.s1067 · Cited by 74
Callanan, D., Kunimoto, D., Maturi, R. K., Patel, S. S., Staurenghi, G., Wolf, S., Cheetham, J. K., Hohman, T. C., Kim, K., López, F. J., et al. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0062 · Cited by 73
Villarroel, M., García‐Ramírez, M., Corraliza, L., Hernández, C., & Simó, R. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.07.017 · Cited by 71
Ohsugi, Y., & Kishimoto, T. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.5.669 · Cited by 69
NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications
Urner, S., Ho, F., Jha, J. C., Ziegler, D., & Jandeleit-Dahm, K. A. M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8047 · Cited by 69
Drug delivery via the suprachoroidal space for the treatment of retinal diseases
Naftali Ben Haim, L., & Moisseiev, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070967 · Cited by 68
Hashemi, H., Rezvan, F., Pakzad, R., Ansaripour, A., Heydarian, S., Yekta, A., Ostadimoghaddam, H., Pakbin, M., & Khabazkhoob, M. (2019) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1962920 · Cited by 66
Li, W., Sinclair, S. H., & Xu, G.-T. (2010) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20091230-03 · Cited by 65
Zhang, C., Xie, H., Yang, Q., Yang, Y., Li, W., Tian, H., Lü, L., Wang, F., Xu, J., Gao, F., et al. (2019) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13619 · Cited by 65
Self-citationMetabolomics in Diabetic Retinopathy: A Systematic Review
Hou, X.-W., Wang, Y., & Pan, C. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.10.4 · Cited by 63
Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent
Jones, J. A., & Francis, P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903188425 · Cited by 62
Gustavsson, C., Agardh, C., & Agardh, E. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02430.x · Cited by 62
Shaw, L. T., Mackin, A. G., Shah, R., Jain, S., Jain, P., Nayak, R., & Hariprasad, S. M. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1763953 · Cited by 62
Dugel, P. U., Boyer, D. S., Antoszyk, A. N., Steinle, N. C., Varenhorst, M. P., Pearlman, J. A., Gillies, M. C., Finger, R. P., Baldwin, M. E., & Leitch, I. M. (2019) · Ophthalmology Retina · doi:10.1016/j.oret.2019.10.008 · Cited by 61
Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates
Lai, C.-M., Estcourt, M. J., Himbeck, R. P., Lee, S.-Y., Yeo, I., Luu, C. D., Loh, B. K., Lee, M. W., Barathi, V. A., Villano, J., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.169 · Cited by 60
McDowell, R. E., Barabás, P., Augustine, J., Chevallier, O. P., McCarron, P., Chen, M., McGeown, J. G., & Curtis, T. M. (2018) · Diabetologia · doi:10.1007/s00125-018-4707-y · Cited by 60
Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes
Noda, K., Nakao, S., Zandi, S., Engelstädter, V., Mashima, Y., & Hafezi‐Moghadam, A. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.07.010 · Cited by 58
A collagen IV–derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling
Mirando, A. C., Shen, J., Silva, R. L. E., Chu, Z., Sass, N. C., Lorenc, V. E., Green, J. J., Campochiaro, P. A., Popel, A. S., & Pandey, N. B. (2019) · JCI Insight · doi:10.1172/jci.insight.122043 · Cited by 57
Gu, L., Han, X., Wang, F., Xu, G., Sinha, D., Wang, J., Xu, J., Tian, H., Gao, F., Li, W., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14435 · Cited by 56
Self-citationBiosimilars for Retinal Diseases: An Update
Sharma, A., Kumar, N., Parachuri, N., Bandello, F. M., Kuppermann, B. D., & Loewenstein, A. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.11.017 · Cited by 56
Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema
Barakat, M. R., Wykoff, C. C., Gonzalez, V., Hu, A., Marcus, D., Zavaleta, E., & Ciulla, T. A. (2021) · Ophthalmology Retina · doi:10.1016/j.oret.2020.08.007 · Cited by 55
Anti-integrin therapy for retinovascular diseases
Bhatwadekar, A. D., Kansara, V. S., Luo, Q., & Ciulla, T. A. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1795639 · Cited by 54
Future of anti-VEGF: biosimilars and biobetters
Kapur, M., Nirula, S., & Naik, M. P. (2022) · International Journal of Retina and Vitreous · doi:10.1186/s40942-021-00343-3 · Cited by 54
Ahmet, I., Tae, H., Juhaszova, M., Riordon, D. R., Boheler, K. R., Sollott, S. J., Brines, M. L., Cerami, A., Lakatta, E. G., & Talan, M. I. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00235 · Cited by 53
KSI-301: antibody biopolymer conjugate in retinal disorders
Chandrasekaran, P. R., & Madanagopalan, V. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211027708 · Cited by 53
Jiang, M., Xie, H., Zhang, C., Wang, T., Tian, H., Lü, L., Xu, J., Xu, G., Liu, L., & Zhang, J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17179 · Cited by 53
Self-citationSharma, S., Purohit, S. B., Sharma, A., Hopkins, D., Steed, L., Bode, B. W., Anderson, S. W., Caldwell, R. B., & She, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/279393 · Cited by 52
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration
Jackson, T. L., Boyer, D. S., Brown, D. M., Chaudhry, N. A., Elman, M. J., Liang, C., O’Shaughnessy, D., Parsons, E. C., Patel, S. S., Slakter, J. S., et al. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.1571 · Cited by 49
Mesquida, M., Drawnel, F., Lait, P. J. P., Copland, D. A., Stimpson, M. L., Llorenç, V., de la Maza, M. S., Adán, A., Widmer, G., Strassburger, P., et al. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.5.32 · Cited by 49
Emerging therapies and their delivery for treating age‐related macular degeneration
Thomas, C. N., Sim, D. A., Lee, W. H., Alfahad, N., Dick, A. D., Denniston, A. K., & Hill, L. J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15459 · Cited by 49
Functional Implication of Dp71 in Osmoregulation and Vascular Permeability of the Retina
Sène, A., Tadayoni, R., Pannicke, T., Wurm, A., Mathari, B. E., Bénard, R., Roux, M. J., Yaffe, D., Mornet, D., Reichenbach, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007329 · Cited by 48
Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema
Chhablani, J. K., Alshareef, R. A., Kim, D. T., Narayanan, R., Goud, A., & Mathai, A. (2018) · BMC Ophthalmology · doi:10.1186/s12886-018-0841-z · Cited by 48
Khurana, R. N., Kunimoto, D. Y., Yoon, Y. H., Wykoff, C. C., Chang, A., Maturi, R. K., Agostini, H. T., Souied, E. H., Chow, D. R., Lotery, A. J., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.11.017 · Cited by 42
Bromfenac Eyedrops in the Treatment of Diabetic Macular Edema: A Pilot Study
Pinna, A., Blasetti, F., Ricci, G. D., & Boscia, F. (2016) · European Journal of Ophthalmology · doi:10.5301/ejo.5000888 · Cited by 41
Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy
Sharma, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.689429 · Cited by 41
Atzori, M. G., Tentori, L., Ruffini, F., Ceci, C., Bonanno, E., Scimeca, M., Lacal, P. M., & Graziani, G. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244434 · Cited by 39
Emerging drugs for the treatment of diabetic retinopathy
Striglia, E., Caccioppo, A., Castellino, N., Reibaldi, M., & Porta, M. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1801631 · Cited by 39
Liu, D., Xu, H., Zhang, C., Xie, H., Yang, Q., Li, W., Tian, H., Lü, L., Xu, J., Xu, G., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118273 · Cited by 39
Self-citationSaxena, S., Ruia, S., Prasad, S., Jain, A., Mishra, N., Natu, S. M., Meyer, C. H., Gilhotra, J. S., Kružliak, P., & Akduman, L. (2016) · Retina · doi:10.1097/iae.0000000000001163 · Cited by 38
Li, J., Lu, Q., & Lu, P. (2018) · BMC Ophthalmology · doi:10.1186/s12886-018-0821-3 · Cited by 38
EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells
Zhong, Y. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e355 · Cited by 37
Clementi, M. E., Pizzoferrato, M., Bianchetti, G., Brancato, A., Sampaolese, B., Maulucci, G., & Tringali, G. (2022) · Biomedicines · doi:10.3390/biomedicines10020503 · Cited by 37
Lee, S. H. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0821-9 · Cited by 36
EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy
Xu, G. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e234 · Cited by 34
Wang, Z., Tang, J., Jin, E., Zhong, Y., Zhang, L., Han, X., Liu, J., Cheng, Y., Hou, J., Shi, X., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.871291 · Cited by 33
Monickaraj, F., Oruganti, S. R., McGuire, P. G., & Das, A. (2020) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-04884-5 · Cited by 32
Ţălu, Ş., & Nicoară, S. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.437 · Cited by 32
Srividya, G., Jain, M., Mahalakshmi, K., Gayathri, S., Raman, R., & Angayarkanni, N. (2018) · Eye · doi:10.1038/eye.2017.285 · Cited by 31
Port delivery system: a novel drug delivery platform to treat retinal diseases
Khanani, A. M., Aziz, A. A., Weng, C. Y., Lin, W. V., Vannavong, J., Chhablani, J. K., Danzig, C. J., & Kaiser, P. K. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1968826 · Cited by 31
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Wang, T., Zhang, C., Xie, H., Jiang, M., Tian, H., Lü, L., Xu, G., Liu, L., & Zhang, J. (2021) · Eye and Vision · doi:10.1186/s40662-021-00237-3 · Cited by 30
Self-citationClementi, M. E., Maulucci, G., Bianchetti, G., Pizzoferrato, M., Sampaolese, B., & Tringali, G. (2021) · Antioxidants · doi:10.3390/antiox10020192 · Cited by 28
Qin, S., Zhang, C., Qin, H., Xie, H., Luo, D., Qiu, Q., Liu, K., Zhang, J., Xu, G., & Zhang, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.791442 · Cited by 28
Self-citationInhibition of experimental choroidal neovascularization in rats by an av-integrin antagonist
Yasukawa, T., Hoffmann, S. R. K., Eichler, W., Friedrichs, U., Wang, Y., & Wiedemann, P. (2004) · Current Eye Research · doi:10.1076/ceyr.28.5.359.28678 · Cited by 27
Xu, G., Kang, D., Zhang, C., Lou, H. P., Sun, C., Yang, Q., Lü, L., Xu, G., Zhang, J., & Wang, F. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18093 · Cited by 27
Self-citationReprogramming the metabolome rescues retinal degeneration
Park, K. S., Xu, C. L., Cui, X., & Tsang, S. H. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2744-9 · Cited by 26
Anti-VEGF effects of intravitreal erythropoietin in early diabetic retinopathy
Xu, G.-T. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e151 · Cited by 25
Metadata
- Authors
- Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-10-25
- Volume
- 11
- Issue
- 21
- Pages
- 3362
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4307370122
- Cited by
- 300
- References
- 210
- FWCI
- 38.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.